Profound Medical Corp. - Common Shares (PROF)

CUSIP: 74319B502

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
-352,911
SEC-reported price per share
$5.90
Indexed holders
44
Value change
-$2,042,016
Number of buys
20
Number of sells
21
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
29,881,634

Security key

74319B502

Report period

Q2 2025

Indexed institutions

44

Top holders

10

Ownership snapshot

Top reported holders of PROF - Profound Medical Corp. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GAGNON SECURITIES LLC
Disclosed value leader
GAGNON SECURITIES LLC
Comparable rows
2/15
Latest evidence
15 May 2025
13D/G 13F 3/4/5 Lead comparable stake: 11% 13 rows are not safely comparable across share classes. 13D/G row: GAGNON SECURITIES LLC Showing 1-6 of 15 holder rows.

Quick read

GAGNON SECURITIES LLC leads the comparable SEC ownership view at 11%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GAGNON SECURITIES LLC's linked filing trail.
Comparable ownership Top 2
GAGNON SECURITIES LLC 11%
LETKO, BROSSEAU & ASSOCIATES INC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GAGNON SECURITIES LLC
13D/G 13F
Neil Gagnon · Company
11%
Reported 13D/G · 31 Dec 2024
$15,796,627
3,346,743 shares
$0 31 Dec 2024
LETKO, BROSSEAU & ASSOCIATES INC
13F 13D/G
Company
4.9%
Reported 13D/G · 30 Sep 2024
$5,917,111
1,207,850 shares
— 31 Mar 2025
FIL Ltd
13F
Company
13F
—
denominator unverified
$10,563,299
1,815,000 shares
— 31 Mar 2025
Timelo Investment Management Inc.
13F
Company
13F
—
denominator unverified
$5,767,591
990,995 shares
— 31 Mar 2025
Gagnon Advisors, LLC
13F
Company
13F
—
denominator unverified
$5,218,625
896,671 shares
— 31 Mar 2025
RAYMOND JAMES FINANCIAL INC
13F
Company
13F
—
denominator unverified
$5,196,556
892,879 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
44
Shares
12,482,340
Indexed holders
44
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 indexed holders
48
Q2 2025 indexed holders
44
Indexed holder difference
-4
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .